by admin | Feb 23, 2023 | News & Opinions
Cedars-Sinai Cancer Stem Cell Transplant and Cellular Therapy Program Receives Expanded Accreditation and Top Ranking for Patient Survival Rates by Christina Elston – Cedars Sinai Image: Illustration of CAR (chimeric antigen receptor) T cell immunotherapy, a...
by admin | Feb 22, 2023 | News & Opinions
He Jiankui refused to answer researchers’ questions about his controversial 2018 experiments at weekend event. by Smriti Mallapaty – Nature.com He Jiankui, the Chinese biophysicist who shocked the world with experiments that led to the first children with edited...
by admin | Feb 21, 2023 | News & Opinions
By Nadine A Yehya – UC Davis Health California’s stem cell agency funds the potential gene editing DMD therapy SACRAMENTO, CA – UC Davis Professor Aijun Wang and his team are collaborating with Murthy laboratory at UC Berkeley to develop a much-needed cure...
by admin | Feb 21, 2023 | News & Opinions
By Dillon, H.T., Foulkes, S., Horne-Okano, Y.A. – Nature – Scientific Reports Abstract Premature cardiovascular mortality is increased in long-term allogeneic stem cell transplant (allo-SCT) survivors, but little information exists regarding subclinical...
by admin | Feb 20, 2023 | News & Opinions
By Genetic Engineering and Biotechnology News Results of a largescale collaborative project led by scientists at the Cedars-Sinai Medical Center, Los Angeles, and the University of California, Irvine (UCI), were published in the journal Neuron this week “Large-scale...
by admin | Feb 15, 2023 | News & Opinions
By Paul Hanaphy – 3d Printing Industry Researchers at the USA’s National Eye Institute (NEI) have developed a way of 3D bioprinting eye tissues using patient stem cells. Using their approach, in which three different types of immature choroidal cells are printed...
